IceCure Medical Ltd
ICCM
$0.9512
$0.00120.13%
NASDAQ
12/31/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | ||
---|---|---|---|---|---|
Revenue | -- | 3.34M | 3.26M | 3.23M | |
Total Other Revenue | -- | -- | -- | -- | |
Total Revenue | -- | 3.34M | 3.26M | 3.23M | |
Cost of Revenue | -- | 1.99M | 2.01M | 1.93M | |
Gross Profit | -- | 1.35M | 1.25M | 1.30M | |
SG&A Expenses | -- | 8.14M | 8.41M | 8.60M | |
Depreciation & Amortization | -- | -- | -- | -- | |
Other Operating Expenses | -- | -- | -- | -- | |
Total Operating Expenses | -- | 17.75M | 18.53M | 18.81M | |
Operating Income | -- | -14.42M | -15.27M | -15.58M | |
Income Before Tax | -- | -13.69M | -14.49M | -14.65M | |
Income Tax Expenses | -- | -- | -- | -- | |
Earnings from Continuing Operations | -- | -13.69 | -14.49 | -14.65 | |
Earnings from Discontinued Operations | -- | -- | -- | -- | |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
Minority Interest in Earnings | -- | -- | -- | -- | |
Net Income | -- | -13.69M | -14.49M | -14.65M | |
EBIT | -- | -14.42M | -15.27M | -15.58M | |
EBITDA | -- | -14.08M | -14.94M | -15.25M | |
EPS Basic | -- | -0.29 | -0.32 | -0.32 | |
Normalized Basic EPS | -- | -0.08 | -0.09 | -0.09 | |
EPS Diluted | -- | -0.29 | -0.32 | -0.32 | |
Normalized Diluted EPS | -- | -0.08 | -0.09 | -0.09 | |
Average Basic Shares Outstanding | -- | 187.01M | 183.66M | 182.55M | |
Average Diluted Shares Outstanding | -- | 187.01M | 183.66M | 182.55M | |
Dividend Per Share | -- | -- | -- | -- | |
Payout Ratio | -- | -- | -- | -- |